Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Frontera Therapeutics
company
About
Frontera Therapeutics is an AAV gene therapy company that focuses on rAAV therapies for the global market.
- 101 - 250
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $160M
- Industries
- Biotechnology
- Founded date
- Sep 1, 2019
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$160M
Frontera Therapeutics has raised a total of
$160M
in funding over 2 rounds. Their latest funding was raised on
Jun 24, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 24, 2022 | Series B | $160M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Frontera Therapeutics is funded by 1 investors.
Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
